Investorideas.com newswire, breaking news for marijuana, cannabis and hemp stocks

Thursday 2 May 2019

Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move- (CSE: $SLNG.C) (NYSE: $CGC) (CSE: $TER.C) (CSE: $MYM.C) (CSE: $CURA.C)


Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move- (CSE: $SLNG.C) (NYSE: $CGC) (CSE: $TER.C) (CSE: $MYM.C) (CSE: $CURA.C)



Delta, Kelowna, BC –May 2, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

Read this in full at


Today’s podcast overview/transcript:
Good morning and welcome to another episode of Investorideas.com “potcasts”, looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today’s podcast I focus on a few early announcements from some interesting companies.

SLANG Worldwide Inc. (CSE: SLNG), a leading global cannabis consumer packaged goods company with a robust portfolio of renowned brands distributed across 2,600 stores in 11 US states, announced the establishment of its new wellness-focused business division, SLANG Health and Wellness. The new business unit will develop and market a portfolio of plant-based cannabidiol products that will be distributed in partnership with Greenlane Holdings, Inc. (NASDAQ: GNLN) through their extensive distribution network.

"Consumers are increasingly interested in natural plant-based wellness products, and we've only scratched the surface of the opportunity within cannabinoid-supported wellness," said SLANG CEO Peter Miller. "Health and Wellness represents a new market segment for SLANG and is a natural extension for our portfolio of top selling products across the US and internationally. We expect early sales to be supported by the brand awareness and customer loyalty that we've developed within our existing portfolio over many years of innovation and
consumer focus."

SLANG Health and Wellness products will target a rapidly expanding and promising consumer market that is expected to grow from US$591 million in 2018 to US$22 billion by 2022, according to The Brightfield Group. The Company will initially focus on extending SLANG's existing industry leading portfolio of THC-dominant products into the CBD space and will immediately launch sales of the Company's best-selling O.penVAPE Reserve brand, to be sold as a half gram hemp-based CBD cartridge.

Canopy Growth Corporation(TSX: WEED) (NYSE: CGC) announced that it has acquired German-based, Bionorica SE-founded C3 Cannabinoid Compound Company in a transformative deal that will see established single cannabinoid medicines brought together with the world's leading full-spectrum medical cannabis offering.
                             
The all cash-acquisition for €225.9 million (CDN $342.9 million) furthers Canopy Growth's expansion into European markets with prescription medicines and gives the Company immediate access to a wealth of knowledge and intellectual property that C3 has developed in its nearly 20 years of research and development into synthetic and natural cannabis medical products.

C3's primary medicinal offering is dronabinol, a pure chemical compound with standardized concentrations of tetrahydrocannabinol (THC), one of the active ingredients found in cannabis plants that is responsible for various pharmacological effects. Dronabinol is available in Austria, Denmark, and Germany for nausea and vomiting refractory to conventional treatment in oncology and palliative care, and for cancer pain. In Germany, dronabinol can be prescribed for any type of chronic pain and for any condition in palliative care. C3 has a total of five medicines in the market and its commercial operations generated €27.1 million (CDN $41.5 million) in 2018.
                             
The acquisition will allow Canopy Growth to further empower European physicians with the knowledge and therapies drawn from the full range of synthetic to naturally-derived cannabinoid-based medicines. Adding dronabinol to Canopy Growth's product offering in Europe and potentially other key markets will allow the Company's medical division, Spectrum Cannabis, to present an expanded, medically validated suite of cannabinoid therapies to the benefit of healthcare professionals and patients. Furthermore, C3's infrastructure including production, distribution, and sales & marketing significantly adds to the Spectrum Cannabis footprint in Europe, including an expanding product line and additional reach into pharmacy and medical specialists' networks.

TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) today announced that its manufacturing facility in Mississauga, Ontario, Canada has been issued a Good Manufacturing Practice certificate in accordance with the rules governing medicinal products in the European Union.

The EU GMP certification was awarded by the responsible agency, Arzneimittelbehörde, in North Rhine-Westphalia, Germany. Additionally, the Company has entered a comprehensive sales and distribution agreement with iuvo Therapeutics GmbH, a German pharmaceutical wholesaler with a cannabis-specific import and distribution license. TerrAscend expects to begin distribution through iuvo this quarter.

"Just five months ago, TerrAscend became the first North American Operator (NAO), with scale operations in both Canada and the US. Upon commencement of shipments this quarter, through our partner iuvo in Germany, TerrAscend will be the first and only global cannabis operator with sales in the three largest markets in the world," said Dr. Michael Nashat, CEO of TerrAscend. "We will continue to expand our sales footprint going forward and will share news of these milestones as we achieve them."

MYM Nutraceuticals Inc., (CSE: MYM) (OTCBB: MYMMF) announced that the Company has acquired 50% of BioHemp Naturals ("BioHemp"), a licensed hemp cultivator in the business of cultivating and distributing CBD-rich hemp biomass to licensed producers in Canada. BioHemp co-founder, Len Atkinson, will join the MYM management team as Global Hemp Project Manager.

BioHemp's founder has been growing hemp since 2015 and developed unique harvesting methods and standard operating procedures which meet all Health Canada testing requirements for hemp. BioHemp is expanding its hemp operations to cultivate 450 acres this 2019 season with plans to expand to 3,000 acres of certified organic hemp in 2020. Forecasted revenues based on the sale of biomass for the 2019 grow season are expected to exceed $30 million with 2020 grow season $225 million.The partnership will allow BioHemp to toll-process the hemp flower through MYM's planned extraction plant which would significantly increase revenues for both seasons.

"Acquiring 50% of BioHemp Naturals and engaging Mr. Atkinson as MYM's Global Hemp Project Manager is a huge win for MYM and our stated goal to become global CBD-rich hemp cultivators, extractors, and distributors," said Howard Steinberg, CEO of MYM. "The addition of BioHemp Naturals adds over 3,000 acres of cultivation to the company which is expected to significantly increase future revenues of MYM."

Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ,  a leading vertically integrated cannabis operator in the United States, unveiled its new Arizona initiative with the Veterans Cannabis Project (VCP), an organization that advocates for legal and supported access of medical cannabis for veterans through the Department of Veterans Affairs. Patients at Curaleaf's five Arizona locations can purchase a custom-designed "Veterans Cannabis Project" pre-roll product, with a portion of all proceeds benefiting the VCP. Each box includes five pre-rolls and will be available for $16.

Veterans and concerned citizens also participated in the launch of a nationwide petition and grassroots campaign supporting medical cannabis. The campaign urges Congress to authorize access, provide protections, and require research into medical cannabis. Additionally, it calls for the Department of Veterans Affairs to give veterans access to the cannabis they overwhelmingly want and deserve.  The petition can be accessed here: https://www.vetscp.org/act.

To celebrate the launch, local veterans visited Curaleaf's Midtown location to hear Dr. Sue Sisley, an Arizona scientist who conducted the first FDA-approved study of cannabis for PTSD in veterans, speak about her recent research. Steve Cottrell, President of Curaleaf Arizona, and Doug Distaso, Executive Director of VCP, also spoke about the new initiative aimed at raising awareness and support around veterans' access.

Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com  website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   


Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Follow us on Social Media

Contact Investorideas.com
800-665-0411




 Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directories




Wednesday 1 May 2019

Investorideas.com - CBD Tech News: Optivida Health Contracts with Frelii (OTCQB: FRLI) for DNA Sequencing Services to Maximize Hemp Extract and CBD Use, Alignment & Understanding by Customers

Investorideas.com - CBD Tech News: Optivida Health Contracts with Frelii (OTCQB: FRLI) for DNA Sequencing Services to Maximize Hemp Extract and CBD Use, Alignment & Understanding by Customers

Investorideas.com - Tech-Holdings Launches 420 AntiDōs

Investorideas.com - Tech-Holdings Launches 420 AntiDōs

Investorideas.com - The State Of Sonoma County Cannabis With Susan Gorin

Investorideas.com - The State Of Sonoma County Cannabis With Susan Gorin

Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move- (CSE: $CURA.C) (OTCQX: $CURLF), (CSE: $CXXI.C) (CSE: $SPR.C) (OTC: $SRUTF)


Investor Ideas #Potcasts: #Cannabis News and #Stocks on the Move- (CSE: $CURA.C) (OTCQX: $CURLF), (CSE: $CXXI.C) (CSE: $SPR.C) (OTC: $SRUTF)

News from Province Brands, HelloMD, Panaxia Pharmaceutical Industries Israel



Delta, Kelowna, BC –May 1, 2019 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s edition of Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:




Today’s podcast overview/transcript:
Good morning and welcome to another episode of Investorideas.com “potcasts”, looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today’s podcast I focus on a few early announcements from some interesting companies.

But first, HelloMD will now provide patients in Canada with convenient access to practitioner-led advice about medical cannabis through a new relationship with Shoppers Drug Mart's online medical cannabis platform.

Since its launch in 2015, HelloMD's turnkey telehealth platform has facilitated more than 100,000 virtual consults between medical cannabis patients and licensed practitioners. HelloMD is currently active in Canada and the United States.

The Medical Cannabis by Shoppers website now features a dedicated portal operated by HelloMD. Patients can access live video consultations with licensed healthcare practitioners through the dedicated portal seven days a week, from the comfort of their home.
Following a consultation with a healthcare practitioner, patients that receive a medical document authorizing their registration as a medical cannabis patient may return to the Medical Cannabis by Shoppers website to register and begin choosing from its wide selection of approved products, or direct HelloMD to send their medical document to an alternative licensed producer.

Panaxia Pharmaceutical Industries Israel and the pharmaceutical company Rafa, announced the signing of a collaboration agreement with PlantEXT Ltd., an Israeli-Canadian medical cannabis company. According to the agreement, the parties will co-develop the next generation of medical cannabis products intended for patients suffering from Inflammatory Bowel Disease, and who are authorized to receive treatment with medical cannabis. The treatment consists of medical cannabis suppositories, which contain a proprietary composition based on a combination of defined and precise active ingredients from the cannabis plant. The novelty lies in the fact that for the first time, a medical cannabis product will be developed in order to offer a targeted solution to patients suffering from Crohn's disease and Colitis, in order to decrease the level of inflammation in the intestine.
Inflammatory bowel disease (Crohn's or Ulcerative Colitis) are chronic diseases that can appear at any age. Now for the first time, treatment with medical cannabis for these patients will be delivered utilizing an accepted, conventional pharmaceutical delivery system, and which is based on clinical research. This will offer a potential solution and increase accessibility of the treatment to a greater number of patients who need it and are eligible to receive it.

The active ingredients in the rectal cannabis suppositories are absorbed at a relatively fast rate through the many blood vessels and are not first metabolized by the liver, unlike medications that are taken orally. As a result, the biological availability of the active ingredients rises on the one hand, and a speedy physical response occurs on the other hand.

According to Dr. Dadi Segal, Panaxia CEO, "Panaxia has already gained proven and successful experience with cannabis suppositories in the American market. The agreement that was signed today is an additional milestone in revolutionizing accessibility of medical cannabis also in Israel, which we are leading together with Rafa. By enabling cannabis accessibility via traditional pharmaceutical delivery systems, and which are not based on smoking, we are striving to enable patients who are eligible for medical cannabis treatment, for a wide range of diseases, to be able to benefit from its unique attributes, subject at all times to the advice of a qualified medical specialist."


Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF), a leading vertically integrated cannabis operator in the United States, today announced it has signed a definitive agreement to acquire the state-regulated cannabis business of Cura Partners, Inc., owners of the Select brand, in an all-stock transaction valued at C$1.27 billion or US$948.8 million.
The acquisition includes Select's manufacturing, processing, distribution, marketing and retailing operations and all adult-use cannabis products marketed under the Select brand name, including all intellectual property. Based in Portland, Oregon, Select is the most well-known cannabis wholesale brand in the country. With its THC products sold in more than 900 retailers, it is the leading cannabis brand in key Western states, including California, Arizona, Oregon and Nevada.

The highly complementary acquisition brings together two of the strongest cannabis brands, Curaleaf and Select, to offer a full-range of products across the U.S. The combination will provide immediate geographic diversification with Curaleaf's footprint on the East Coast and Select's brand strength on the West Coast.

The proposed transaction combines Curaleaf's retail locations, vertical integration, wellness brand and strong East Coast market presence with Select's wholesale model, lifestyle brand and leading West Coast market presence. Significant cost synergies are expected to be realized through operational efficiencies, greater economies of scale, supply chain efficiencies and increased vertical integration.

C21 Investments, Inc. (CSE: CXXI) today announced the launch of a new product: the Phantom Vape Pen. The highly anticipated vape pen solves a number of industry challenges by providing uniform viscosity, shelf stability, oil clarity as well as consistency of flavour and potency.

"Vaping is the main driver of concentrate sales, which are projected to reach $8.4 billion in USA sales by 2022," said Sky Pinnick, Chief Marketing Officer, C21 Investments.  "Our strategy for the Phantom Vape Pen was to provide an affordable, superior product at a highly competitive price point helping to bridge the gap for flower traditionalists to high quality concentrates."
         
The Phantom Vape Pen is made by Phantom Farms, a Clean Green Certified cannabis cultivator in Oregon. Using the industry leading CCELL technology with Phantom Farms proprietary terpene-heavy CO2 + distillate extract formulation, the Phantom Vape Pen provides native flavour (terpene) retention, and consistent potency and vaporization experience.

Sproutly Canada, Inc. (CSE: SPR) (OTC: SRUTF), and OCC Holdings Ltd., an affiliate of Moosehead Breweries Limited, announced that they have entered into a definitive agreement to form an exclusive joint venture to develop, produce, and market nonalcoholic cannabis-infused beverages in Canada using Sproutly’s proprietary, naturally produced water soluble cannabinoids known as ‘Infuz2O’. Both companies will bring their respective strengths to the joint venture to develop a line of great tasting cannabis beverages featuring a rapid onset and offset effect unique to the category. Sproutly also hosted a conference call with Keith Dolo, CEO, Sproutly Canada and Matthew Oland, Moosehead executive and incoming CEO of the JV, at 9:30am Eastern Time this morning on May 1, 2019.

Dooma Wenshuh, CEO and Co-Founder of Province Brands commented on this announcement, saying “We are delighted to see the excitement and build-up to the next phase of cannabis legalization in Canada later this year.  With today’s news of Sproutly & Moosehead coming after recent match-ups from AB InBev & Tilray, Constellation Brands & Canopy Growth, Heineken & CannaCraft, and Molson-Coors & Hexo there can be little doubt that beverages will be the dominant form of cannabis consumption in the years ahead.”

“Above these headlines, Province Brands of Canada continues to stand out as the only beverage maker that will deliver beer brewed entirely from the cannabis plant, not an infused concoction, thus providing consumers with the experience of authenticity, high-quality, and choice that they demand.”

Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com  website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment   


Subscribe to the new cannabis podcast series:


To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and  sector trends  from Investorideas.com with our news alerts , articles , podcasts and videos  talking about cannabis,  crypto,  technology including  AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts #Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change Podcast and  the AI Eye Podcast and column covering developments in AI. 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Follow us on Social Media

Contact Investorideas.com
800-665-0411


Investorideas.com - Upcoming Canadian Consumables Market Expected This Fall: Beer and Cannabis Combine (CSE: $SPR.C) (OTCQB: $SRUTF) (NYSE: $CGC) (TSXV: $BEER) (NYSE: $HEXO)

Investorideas.com - Upcoming Canadian Consumables Market Expected This Fall: Beer and Cannabis Combine (CSE: $SPR.C) (OTCQB: $SRUTF) (NYSE: $CGC) (TSXV: $BEER) (NYSE: $HEXO)

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Weeding through the Winners in Cannabis Stocks (TSX: WEED) (Nasdaq: CGC) (NASDAQ: TLRY) (NASDAQ: ACB)

Weeding through the Winners in Cannabis Stocks (TSX: WEED) (Nasdaq: CGC) (NASDAQ: TLRY) (NASDAQ: ACB) : Weeding through the Winners in Canna...